Hülser P J, Kornhuber A W, Kornhuber H H
Department of Neurology, University of Ulm, FRG.
Eur Neurol. 1990;30 Suppl 2:35-8; discussion 39-41. doi: 10.1159/000117190.
Medical treatment in acute stroke is probably more successful when started rapidly after the onset of symptoms. Therefore a drug is necessary which can be applied by the first physician prior to the diagnosis ischaemic versus haemorrhagic stroke by means of imaging methods. In animal models of ischaemic cerebral damage, a cerebroprotective effect of some calcium antagonists could be demonstrated, among them flunarizine and nimodipine. Flunarizine is effective also in experimental cerebral haemorrhage. The results of the first clinical trials with calcium antagonists are encouraging but inconclusive up to now. In view of the limited possibilities of treatment after a stroke, prevention is stressed.
急性中风发作后若能迅速开始治疗,医疗效果可能更佳。因此,需要一种药物,以便首位接诊医生在通过成像方法诊断出是缺血性中风还是出血性中风之前就能使用。在缺血性脑损伤的动物模型中,已证实某些钙拮抗剂具有脑保护作用,其中包括氟桂利嗪和尼莫地平。氟桂利嗪在实验性脑出血中也有效。目前,钙拮抗剂的首批临床试验结果令人鼓舞,但尚无定论。鉴于中风后治疗手段有限,预防受到重视。